Breaking News Instant updates and real-time market news.

AET

AET

, CVS

CVS Health

$66.36

-0.57 (-0.85%)

18:06
06/12/18
06/12
18:06
06/12/18
18:06

After judge clears AT&T-Time Warner deal, other deal stocks pop

After a federal judge cleared the way for AT&T's (T) $85.4B purchase of Time Warner (TWX), other publicly traded companies with pending deals are moving higher. WAVE OF TAKEOVERS EXPECTED: The New York Times said "A federal judge on Tuesday approved the blockbuster merger between AT&T and Time Warner, rebuffing the government's effort to block the $85.4b deal, in a decision that is expected to unleash a wave of takeovers in corporate America." PENDING MEGA-DEALS: This past April, Cigna (CI) said that its proposed $54B acquisition of Express Scripts (ESRX) will be reviewed by the U.S. Department of Justice. Currently CVS (CVS) and Aetna (AET) are awaiting regulators approval of their merger: PRICE ACTION: Shares of Time Warner are up, while AT&T shares are down 3%. OTHERS: Shares of Cigna and Express Scripts are up 1% and 5%, respectively, while CVS and Aetna are up 2.5% and 4%.

AET

AET

CVS

CVS Health

$66.36

-0.57 (-0.85%)

CI

Cigna

$178.79

-2.08 (-1.15%)

ESRX

Express Scripts

$79.18

-0.37 (-0.47%)

T

AT&T

$34.35

0.16 (0.47%)

TWX

Acquired by T

$96.19

-0.05 (-0.05%)

  • 12

    Jun

  • 12

    Jun

  • 12

    Jun

AET AET

05/25/18
CHLM
05/25/18
NO CHANGE
Target $204
CHLM
Buy
UnitedHealth news positive for Quest, 'clearing event' for LabCorp, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich commented on last night's announcements by UnitedHealth (UNH) of long-term strategic partnerships with Quest Diagnostics (DGX) and LabCorp (LH) starting January 1, 2019, whereby both labs will be national providers of lab services. In a research note to investors, Ellich said he is "not surprised" by the announcement, adding that it is "clearly a positive" for Quest, as with UnitedHealth's 48M+ covered lives, it will have access to 90% of all insured lives nationally. Conversely, Kevin sees it as a "clearing event" for LabCorp shares, as the exclusive UnitedHealth contract, which was set to expire at the end of this year, was an overhang. In the event LabCorp loses some UnitedHealth volume, he expects the company will be able to mitigate the impact in a variety of ways, including entry into the Aetna (AET) contract and access to its ~22M medical members, which is exclusive to Quest now but in 2019 Aetna has the option to add another preferred lab provider. Ellich has a Buy rating and $204 price target on LabCorp, while he has a Hold rating and $107 price target on Quest Diagnostics.
05/25/18
EVER
05/25/18
NO CHANGE
Target $40.5
EVER
Outperform
Hologic relationship with Quest seems 'healthy,' says Evercore ISI
Evercore IS analyst Vijay Kumar sees "minimal risks" to Hologic (HOLX) from Quest Diagnostics' (DGX) and LabCorp's (LH) contract renegotiations with UnitedHealth (UNH) and Aetna (AET). He estimates Quest and LabCorp together account for about $200M of revenue for Hologic. Hologic received a Supplier Excellence award last year from Quest, which points to "healthy" relationship, Kumar tells investors in a research note. He believes the labs' new contracts bake in a mid-single digit pricing cut, leading a "manageable" 3c-4c of earnings impact to Hologic. Kumar has an Outperform rating on the shares with a $40.50 price target.
05/29/18
05/29/18
UPGRADE

Overweight
Quest Diagnostics upgraded to Overweight after contract awards at Morgan Stanley
As previously reported, Morgan Stanley analyst Ricky Goldwasser upgraded Quest Diagnostics (DGX) to Overweight from Equal Weight, stating that UnitedHealth's (UNH) and Aetna's (AET) decisions to open up lab contracts and establish a long-term strategic partnership with both Quest and LabCorp (LH) signals a more disciplined pricing environment for the forseeable future and raises his confidence in Quest delivering earnings growth at the high end of its 3%-5% long-term goal. Goldwasser raised his price target on Quest shares to $120 from $103.
06/07/18
06/07/18
UPGRADE
Target $210

Overweight
LabCorp upgraded to Overweight at KeyBanc
As previously reported, KeyBanc analyst Donald Hooker upgraded LabCorp (LH) to Overweight from Sector Weight, with a $210 price target. The analyst sees LabCorp and Quest Diagnostics (DGX) benefiting over time from their recent contracts with United Healthcare (UNH) and Aetna (AET). Between LabCorp and Quest Diagnostics, Hooker sees the former as having the more timely valuation.
CVS CVS Health
$66.36

-0.57 (-0.85%)

04/24/18
LEER
04/24/18
NO CHANGE
LEER
Amazon shelving pharma supply efforts to hospitals not surprising, says Leerink
Leerink analyst David Larsen notes that Amazon (AMZN) is said to be shelving its pharmaceutical supply efforts to hospitals, which he does not see as a suprise given several barriers to entry. The consumer market has always been Amazon's core competency, though he expects it will be a long, gradual, and difficult process of building up an online drug portfolio with an initial focus likely on generics. The analyst believes the risk of Amazon entering retail in the near term is reduced significantly. Nonetheless, Larsen thinks risk remains longer term for retail pharmacies such as CVS (CVS) and Walgreens Boots Alliance (WBA).
05/07/18
LOOP
05/07/18
NO CHANGE
Target $68
LOOP
Hold
CVS Health price target lowered to $68 from $73 at Loop Capital
Loop Capital analyst Andrew Wolf lowered his price target on CVS Health (CVS) to $68 and kept his Hold rating after its Q1 results. The analyst notes continued uncertainty around the timing of its planned merger with Aetna (AET) while also pointing to its "near-flat" operating results and guidance. Wolf further notes that the 13% discount with which CVS Health shares trade relative to Walgreens (WBA) is justified given its recent challenges and flat guidance.
05/23/18
CANT
05/23/18
NO CHANGE
Target $202
CANT
Overweight
Aetna risk/reward 'remains compelling,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper believes Aetna's risk/reward "remains compelling" with the shares trading 13% below his fundamental-based price target of $202. Excluding the impact of the CVS Health (CVS) merger, Aetna's 2018 is likely to be a transition year until the company's investments and improved Medicare Star ratings pay dividends in 2019, Halper tells investors in a research note. He keeps an Overweight rating on the shares.
05/03/18
COWN
05/03/18
NO CHANGE
Target $99
COWN
Outperform
CVS Health weakness a buying opportunity, says Cowen
Cowen analyst Charles Ryhee noted CVS shares came under pressure following Q1 results. He believes, however, the weakness is a buying opportunity as his investment thesis remains intact. Ryhee reiterated his Outperform rating and $99 price target on CVS Health shares.
CI Cigna
$178.79

-2.08 (-1.15%)

04/17/18
LEER
04/17/18
NO CHANGE
LEER
Amazon, Trump news positive for drug supply chain, distributors, says Leerink
Leerink analyst Ana Gupte sees the dual pronged news flow on Amazon (AMZN) being unlikely to enter the Hospital drug supply chain, and President Trump poised to give a speech on drug pricing and supply chain reform on April 26 as HHS Secretary Alex Azar solicits ideas for pricing reform as positive for both the drug supply chain across PBMs and drug distributors and biopharma manufacturers that have been roiled by fears of margin compression on both these threats. Within her coverage, the analyst views this as positive for UnitedHealth (UNH) with its Optum Rx PBM, Cigna (CI) with its deal to acquire Express Scripts (ESRX), and Aetna (AET) which has inked a deal with CVS (CVS) in part through equity, as well as Anthem (ANTM) with IngenioRx and Humana (HUM) with or without its potential Walmart (WMT) deal that has a sizable mail order operation.
05/17/18
BARD
05/17/18
NO CHANGE
Target $92
BARD
Outperform
Express Scripts shares should be bought right here, says Baird
Baird analyst Eric Coldwell revisited his thesis on Express Scripts (ESRX) following results, the President's drug pricing proposals, and the recent proxy filing. Despite the White House blueprint not containing any immediate proposals, he believes the shares are unloved and under-owned and are about the same price today as they were before the Cigna (CI) announcement. Coldwell believes the shares should be bought regardless of the Cigna outcome, citing Express Scripts' consistent fundamental performance and improving business outlook. Coldwell reiterated his Outperform rating and $92 price target on Express Scripts shares.
06/06/18
GSCO
06/06/18
UPGRADE
Target $212
GSCO
Buy
Cigna upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Stephen Tanal upgraded Cigna to Buy and raised his price target for the shares to $212 from $193.
06/06/18
06/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Valeant (VRX) upgraded to Overweight from Equal Weight at Barclays analyst Douglas Tsao saying Valeant's business has hit an inflection point with its existing business stabilizing, which offers a foundation for the company to enjoy growth driven by upcoming product launches. 2. G-III Apparel (GIII) upgraded to Equal Weight from Underweight at Barclays with analyst Chethan Mallela saying he sees improving visibility following the company's Q1 results. 3. Cigna (CI) upgraded to Buy from Neutral at Goldman Sachs. 4. Shaw Communications (SJR) upgraded to Outperformer from Neutral at CIBC. 5. International Paper (IP) upgraded to Outperform from Sector Perform at RBC Capital with analyst Paul Quinn citing the announcement that International Paper will not make an offer for Smurfit Kappa. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ESRX Express Scripts
$79.18

-0.37 (-0.47%)

05/03/18
LEER
05/03/18
NO CHANGE
Target $80
LEER
Market Perform
Express Scripts price target lowered to $80 from $90 at Leerink
Leerink analyst David Larsen lowered his price target for Express Scripts to $80 from $90 after the company reported mixed Q1 results and mostly reaffirmed prior 2018 guidance. The analyst reiterates a Market Perform rating on the shares.
05/01/18
PIPR
05/01/18
NO CHANGE
PIPR
Overweight
Piper says Regeneron deal with Express Scripts for Praluent 'looks meaningful'
Piper Jaffray analyst Christopher Raymond said Regeneron's (REGN) agreement with Express Scripts (ESRX) to improve Praluent access and make it the exclusive PCSK9 on the latter's preferred formulary may "set a somewhat dubious precedent," but he still sees it as a smart move that can reinvigorate Praluent growth. The analyst, who would expect similar agreements with other payers and PBMs are already in the works, keeps an Overweight rating on Regeneron shares.
05/03/18
PIPR
05/03/18
NO CHANGE
Target $450
PIPR
Overweight
Piper positive on Regeneron's 2018 set-up given Eylea strength, Praluent upside
Piper Jaffray analyst Christopher Raymond said he like the setup for Regeneron (REGN) for the rest of the year following the company's Q1 report. He thinks Eylea's strength can continue, Dupixent demand trends will remain healthy and that its recently announced Express Scripts (ESRX) deal can potentially reinvigorate Praluent and offers second half upside. Raymond maintains his Overweight rating on Regeneron, though he lowered his price target on the shares to $450 from $500 as he reduced his multiple given recent volatility in the space.
T AT&T
$34.35

0.16 (0.47%)

05/01/18
DBAB
05/01/18
NO CHANGE
Target $36
DBAB
Hold
AT&T multiples at 'historical lows,' says Deutsche Bank
Deutsche Bank analyst Matthew Niknam sees value in shares of AT&T with "multiples at historical lows." Despite lowering his earnings estimates by 1%-2%, the analyst says the stock's "heavily discounted valuation is noteworthy." AT&T currently trades at 9.6 times 2018 earnings estimates, which marks its historical trough, Niknam tells investors in a research note. He believes the 6.1% dividend yield should provide additional downside support. Nonetheless, Niknam lowered his price target for AT&T to $36 from $41 and keeps a Hold rating on the shares.
05/02/18
BRRR
05/02/18
NO CHANGE
Target $110
BRRR
Outperform
Odds in favor of Time Warner deal closing, says Barrington
Barrington analyst James Goss said he continues to expect the acquisition of Time Warner (TWX) by AT&T (T) to ultimately gain court approval and his Outperform rating in part reflects the significant gap from the AT&T takeout offer. He also sees relatively modest downside risk in the event of the deal being blocked, given the continued fundamental support based on existing Time Warner assets and operations, he tells investors. Goss maintains a $110 price target on Time Warner shares.
06/07/18
JEFF
06/07/18
DOWNGRADE
Target $35
JEFF
Hold
AT&T downgraded to Hold from Buy at Jefferies
Jefferies analyst John Janedis downgraded AT&T (T) to Hold and lowered his price target for the shares to $35 from $40 after assuming coverage of the name. Pressures in the company's entertainment segment will continue, as virtual multichannel video programming distributors gain share and video options pressure average revenue per user and margins, Janedis tells investors in a research note. He expects the Time Warner (TWX) acquisition to close, but believes there is risk of incremental programming investment at HBO/Turner to drive growth and that the advanced advertising opportunity may take longer to materialize.
05/03/18
RHCO
05/03/18
NO CHANGE
Target $35
RHCO
Hold
AT&T price target lowered to $35 from $40 at SunTrust
SunTrust analyst Greg Miller lowered his price target on AT&T to $35 and kept his Hold rating, saying the company's Q1 results "highlight the various challenges" that it faces. While churn is improving and pre-paid net subscriber additions growth continues, the analyst sees a shift from Pay-TV to OTT model weighing on revenue and margins in the Entertainment and Internet segments.
TWX Acquired by T
$96.19

-0.05 (-0.05%)

04/17/18
PIVT
04/17/18
DOWNGRADE
Target $105
PIVT
Hold
Time Warner downgraded to Hold from Buy at Pivotal Research
Pivotal Research analyst Brian Wieser downgraded Time Warner (TWX) to Hold and lowered his price target for the shares to $105 from $108. The stock's value is driven by current trading levels of AT&T (T) under a presumption that the sale of the company goes through, Wieser tells investors in a research note.
06/01/18
RBCM
06/01/18
NO CHANGE
Target $360
RBCM
Outperform
RBC Capital backs Outperform rating on Netflix post U.S., international surveys
RBC Capital analyst Mark Mahaney reiterated an Outperform rating and $360 price target on Netflix (NFLX) shares following "positive" results from surveys in the U.S., France and German that found higher satisfaction trends, a rising willingness to pay for streaming content and high penetration levels. In the U.S., Mahaney noted that the survey found 55% of respondents watch Netflix, a significant lead over YouTube (GOOGL), Amazon (AMZN) and Hulu (DIS, CMCSA, TWX), adding that while Amazon is showing the fastest penetration growth among Streaming services, three years of data show that Prime customers are "more likely to also subscribe to Netflix." He views Netflix as one of the best derivatives off the strong growth in online video viewing and in Internet connect devices.

TODAY'S FREE FLY STORIES

JCOM

j2 Global

$87.23

0.75 (0.87%)

18:25
05/21/19
05/21
18:25
05/21/19
18:25
Hot Stocks
j2 Global CFO sells 5.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 05

    Jun

NVS

Novartis

$82.38

0.36 (0.44%)

18:24
05/21/19
05/21
18:24
05/21/19
18:24
Hot Stocks
Novartis CEO: We are entering an exciting growth phase for the company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

EADSY

Airbus

$0.00

(0.00%)

18:20
05/21/19
05/21
18:20
05/21/19
18:20
Periodicals
Airbus in talks to find resolution to German arms export row, Reuters says »

Airbus CEO Guillaume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRO

Adecogro

$6.50

0.07 (1.09%)

18:19
05/21/19
05/21
18:19
05/21/19
18:19
Earnings
Adecogro reports Q1 adjusted EBITDA $58.3M, down 5.9% from last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

, GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

18:01
05/21/19
05/21
18:01
05/21/19
18:01
Hot Stocks
Google updates policy on abortion-related ads »

Google said in a post…

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 27

    Oct

HAIN

Hain Celestial

$23.90

0.45 (1.92%)

17:50
05/21/19
05/21
17:50
05/21/19
17:50
Hot Stocks
Engaged Capital raises stake in Hain Celestial to 20.2% from 18.3% »

Engaged Capital raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

17:48
05/21/19
05/21
17:48
05/21/19
17:48
Hot Stocks
Nintendo to end 'Animal Crossing,' 'Fire Emblem' mobile game service in Belgium »

Nintendo announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

  • 11

    Jun

URBN

Urban Outfitters

$27.01

0.05 (0.19%)

17:44
05/21/19
05/21
17:44
05/21/19
17:44
Hot Stocks
Urban Outfitters sees Q2 URBN retail SSS in low single-digit negative range »

Says guidance based on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 04

    Jun

GLD

SPDR Gold Shares

$120.34

-0.31 (-0.26%)

17:42
05/21/19
05/21
17:42
05/21/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 739.69MT from 736.17MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASCMA

Ascent Capital

$0.91

0.0502 (5.87%)

17:38
05/21/19
05/21
17:38
05/21/19
17:38
Hot Stocks
Ascent Capital and Monitronics International announce restructuring support pact »

Ascent Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRS

TriMas

$30.33

0.39 (1.30%)

17:33
05/21/19
05/21
17:33
05/21/19
17:33
Hot Stocks
TriMas VP Joshua Sherbin sells over $646K in company shares »

TriMas VP Joshua Sherbin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUNW

Sunworks

$0.71

-0.1024 (-12.65%)

17:33
05/21/19
05/21
17:33
05/21/19
17:33
Syndicate
Breaking Syndicate news story on Sunworks »

Sunworks files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFUS

Littelfuse

$170.78

1.7 (1.01%)

, SMTC

Semtech

$44.74

0.36 (0.81%)

17:32
05/21/19
05/21
17:32
05/21/19
17:32
Initiation
Littelfuse, Semtech, CTS Corporation, Vishay initiated  »

Cowen initiates discrete…

LFUS

Littelfuse

$170.78

1.7 (1.01%)

SMTC

Semtech

$44.74

0.36 (0.81%)

CTS

CTS Corporation

$27.91

0.33 (1.20%)

VSH

Vishay

$16.43

0.37 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 13

    Jun

  • 27

    Jun

GVA

Granite Construction

$41.46

0.5 (1.22%)

17:31
05/21/19
05/21
17:31
05/21/19
17:31
Hot Stocks
Granite Construction awarded $505M high speed rail contract »

Granite announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

OMC

Omnicom

$80.09

0.69 (0.87%)

17:30
05/21/19
05/21
17:30
05/21/19
17:30
Syndicate
Breaking Syndicate news story on Omnicom »

Omnicom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTEC

TTEC Holdings

$38.68

0.51 (1.34%)

17:26
05/21/19
05/21
17:26
05/21/19
17:26
Hot Stocks
TTEC Holdings EVP DeGhetto sells 35K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 16

    Jun

TDW

Tidewater

$24.80

0.31 (1.27%)

17:25
05/21/19
05/21
17:25
05/21/19
17:25
Hot Stocks
Tidewater director Dick Fagerstal purchases almost $107K shares of company stock »

Tidewater director Dick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

PTCT

PTC Therapeutics

$40.07

2.67 (7.14%)

17:16
05/21/19
05/21
17:16
05/21/19
17:16
Hot Stocks
Point72 Asset Management takes 5.0% passive stake in PTC Therapeutics »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

  • 12

    Jun

DRIO

DarioHealth

$0.72

-0.0095 (-1.30%)

17:10
05/21/19
05/21
17:10
05/21/19
17:10
Syndicate
DarioHealth files to sell common stock, no amount given »

Craig-Hallum Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$113.97

2.08 (1.86%)

, PVH

PVH Corp.

$108.53

2.5075 (2.37%)

17:09
05/21/19
05/21
17:09
05/21/19
17:09
Hot Stocks
PVH Corp. appoints former Ralph Lauren CEO Stefan Larsson to president »

PVH Corp. announced the…

RL

Ralph Lauren

$113.97

2.08 (1.86%)

PVH

PVH Corp.

$108.53

2.5075 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 06

    Jun

  • 20

    Jun

  • 20

    Jun

RICK

RCI Hospitality

$18.91

-0.04 (-0.21%)

17:07
05/21/19
05/21
17:07
05/21/19
17:07
Hot Stocks
RCI Hospitality receives Nasdaq noncompliance notice »

RCI Hospitality Holdings,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPLA

LPL Financial

$83.85

2.06 (2.52%)

17:03
05/21/19
05/21
17:03
05/21/19
17:03
Hot Stocks
LPL Financial to acquire Allen & Company »

LPL Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 11

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$286.50

2.55 (0.90%)

17:01
05/21/19
05/21
17:01
05/21/19
17:01
General news
House Judiciary Committee subpoenas Hope Hicks, Annie Donaldson, CNN says »

According to CNN's …

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$286.50

2.55 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$46.90

0.91 (1.98%)

16:53
05/21/19
05/21
16:53
05/21/19
16:53
Conference/Events
Morgan Stanley healthcare tech analyst to hold analyst/industry conference call »

Healthcare Technology and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 23

    Jun

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

, GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

16:48
05/21/19
05/21
16:48
05/21/19
16:48
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Semiconductor makers…

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

MSFT

Microsoft

$126.90

0.71 (0.56%)

HD

Home Depot

$191.41

0.54 (0.28%)

KSS

Kohl's

$55.15

-7.805 (-12.40%)

JCP

J.C. Penney

$1.06

-0.09 (-7.83%)

CR

Crane

$84.09

-0.8 (-0.94%)

CIR

Circor

$43.09

12.45 (40.63%)

AAPL

Apple

$186.58

3.52 (1.92%)

INTC

Intel

$44.46

0.88 (2.02%)

ARWR

Arrowhead

$21.33

2.39 (12.62%)

ARRY

Array BioPharma

$25.75

4.8 (22.91%)

BCRX

BioCryst

$3.48

-3.92 (-52.97%)

MNK

Mallinckrodt

$9.87

-3.15 (-24.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 25

    Jul

  • 06

    Aug

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.